<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210811052147N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-10-17</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effects of Streptococcus salivarius M18 and K12 probiotic bacteria on the amount of Streptococcus mutans in saliva: a randomized clinical trial</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effects of Streptococcus salivarius M18 and K12 probiotic bacteria on the amount of Streptococcus mutans in saliva: a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-10-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59305</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Individuals are randomly divided into 2 groups of 20 people. In order to maintain the equality of the number of people in both groups, in this study, the limited randomization method of block randomization will be used. Blocking is usually used to balance the number of samples assigned to each of the study groups. This feature helps researchers to equate the number of samples assigned to each of the study groups in cases where intermediate analyzes are required during the sampling process. The size of all the blocks is the same and in this two-group experiment we will have 40 blocks of 20 people including 20 people in the probiotic group and 20 people in the control group (mouth freshener pill).The randomization tool will be the latest version of random allocation software, which in addition to simple randomization will also be able to block randomization. We also use allocation concealment, which is the method used to execute random sequences on study participants so that the assigned group is not known before the individual is assigned. Using opaque envelopes sealed with random sequence (Sequentially numbered, sealed, opaque envelopes) in which in this method each random sequence is recorded on a card and the cards are inside the envelopes respectively. Are placed. In order to maintain a random sequence, the envelopes are numbered in the same way on the outer surface. Finally, the lids of the letter envelopes are glued and placed inside a box, respectively. At the beginning of the registration of participants, based on the order of entry of eligible participants into the study, one of the envelopes of the letter is opened in order and the assigned group of the participant is revealed.</study_design>
      <phase>3</phase>
      <hc_freetext>Dental caries.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: to standardize oral hygiene, both intervention and control groups are given brushing training one week before the intervention. People also use a type of toothpaste for a week before the intervention and at the end of the entire intervention period.  Individuals take a tablet containing the probiotic bacteria Streptococcus salivarius M18 and K12 in their mouth every night before going to bed and suck it until it dissolves and consume this substance for 20 days. This tablet is under the brand name of Lactogam and is a product of Zist Takhmir Company and is made in Iran. These tablets contain 150 mg of M18 bacteria and 150 mg of K12 bacteria. Also, more than 10 to the power of 9 colonies of these bacteria are present in each tablet. The taste of this pill is mint. Intervention 2: Control group: to standardize oral hygiene, both intervention and control groups are given brushing training one week before the intervention. People also use a type of toothpaste for a week before the intervention and at the end of the entire intervention period. Individuals put a mouthwash pill in their mouth at night before going to bed and suck it until it dissolves and consume this substance for 20 days. This pill is under the brand name of Iceberg and made in Iran in Shiva food industry. The sweetener in this pill is xylitol and it is unusable for bacteria in the mouth. Also, the dose of xylitol in each deodorant pill is extremely low and has no therapeutic effect of xylitol. The taste of this pill is mint.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All our data except people names and phone numbers can be published

When:
The data will be available 1 year after the results are published.

To whom:
The data is accessible to academic researchers and industry researchers. It should be noted that this information will be available only to Iranian universities and companies.

Conditions:
If the data is not deleted and changed and the purpose of using the data is clear to the early researchers, it is possible to use the data at the discretion of the early researchers. It should be noted that in case of any discrepancy with moral principles or having bad intentions, this information will not be provided to individuals.

Where to obtain:
Dr. Firoozeh Nilchian
Address: School of Dentistry, Isfahan University of Medical Sciences
Phone: 00983137925594
Email: f_nilchian@dnt.mui.ac.ir
Postal Code: 8174673461

How to obtain:
The application must be mentioned by phone number or email. Then, if the initial researchers agree, the necessary information will be provided to the applicants as soon as possible.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Firoozeh Nilchian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Dentistry , Isfahan University of Medical Sciences , Hezar Jarib Boulvard, Isfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 5594</telephone>
        <email>f_nilchian@dnt.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Firoozeh Nilchian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Dentistry , Isfahan University of Medical Sciences , Hezar Jarib Boulvard, Isfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 5594</telephone>
        <email>f_nilchian@dnt.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>People without orthodontics or people who have had orthodontic treatment for more than six months
People who have not taken antibiotics in the past month
People who do not have incomplete dental treatment
People without immune system diseases</inclusion_criteria>
      <agemin>19 years</agemin>
      <agemax>35 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>People with orthodontic appliques or people who have had orthodontic treatment for less than six months
People who have taken antibiotics in the past month
People undergoing incomplete dental treatment
People with immune system diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K02</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Dental caries</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: to standardize oral hygiene, both intervention and control groups are given brushing training one week before the intervention. People also use a type of toothpaste for a week before the intervention and at the end of the entire intervention period.  Individuals take a tablet containing the probiotic bacteria Streptococcus salivarius M18 and K12 in their mouth every night before going to bed and suck it until it dissolves and consume this substance for 20 days. This tablet is under the brand name of Lactogam and is a product of Zist Takhmir Company and is made in Iran. These tablets contain 150 mg of M18 bacteria and 150 mg of K12 bacteria. Also, more than 10 to the power of 9 colonies of these bacteria are present in each tablet. The taste of this pill is mint.</i_keyword>
      <i_keyword>Control group: to standardize oral hygiene, both intervention and control groups are given brushing training one week before the intervention. People also use a type of toothpaste for a week before the intervention and at the end of the entire intervention period. Individuals put a mouthwash pill in their mouth at night before going to bed and suck it until it dissolves and consume this substance for 20 days. This pill is under the brand name of Iceberg and made in Iran in Shiva food industry. The sweetener in this pill is xylitol and it is unusable for bacteria in the mouth. Also, the dose of xylitol in each deodorant pill is extremely low and has no therapeutic effect of xylitol. The taste of this pill is mint.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The amount of Streptococcus mutans in saliva. Timepoint: Saliva samples are collected at the beginning and end of the intervention. Method of measurement: Bacteria are measured based on colony count.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-10-12</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Isfahan University of Medical Sciences, Hezar Jarib Boulevard, Isfahan, Iran Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
